|
|
||||||||



* Laboratório de Imunofarmacologia, Departamento de Fisiologia e Farmacodinâmica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil;
Centro de Terapia Intensiva, Hospital Universitário Clementino Fraga Filho, and
Departamento de Imunologia, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; and
Harvard Thorndike Laboratories and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
Lipid bodies are rapidly inducible, specialized cytoplasmic domains
for eicosanoid-forming enzyme localization, which we hypothesize to
have specific roles in enhanced inflammatory mediator production during
pathological conditions, including sepsis. However, little is known
about the origins, composition, or functions of lipid bodies in vivo.
We show that lipid body numbers were increased in leukocytes from
septic patients in comparison with healthy subjects. Analogously, the
intrathoracic administration of LPS into mice induced a dose- and
time-dependent increase in lipid body numbers. Pretreatment with
anti-CD14 or anti-CD11b/CD18 mAb drastically inhibited
LPS-induced lipid body formation. Moreover, LPS failed to form lipid
bodies in C3H/HeJ (TLR4 mutated) mice, demonstrating a
requisite role for LPS receptors in lipid body formation. LPS-induced
lipid body formation was also inhibited by the platelet-activating
factor-receptor antagonists, suggesting a role for endogenous
platelet-activating factor. The eicosanoid-forming enzymes,
5-lipoxygenase and cyclooxygenase-2, were immunolocalized within
experimentally induced (LPS in mice) or naturally occurring (septic
patients) lipid bodies. The proinflammatory cytokine involved in the
pathogenesis of sepsis, TNF-
, was also shown to colocalize within
lipid bodies. Prior stimulation of leukocytes to form lipid bodies
enhanced the capacity of leukocytes to produce leukotriene
B4 and PGE2. In conclusion, our studies
indicate that lipid bodies formed after LPS stimulation and sepsis are
sites for eicosanoid-forming enzymes and cytokine localization and may
develop and function as structurally distinct, intracellular sites for
paracrine eicosanoid synthesis during inflammatory
conditions.
This article has been cited by other articles:
![]() |
P. E. Almeida, A. R. Silva, C. M. Maya-Monteiro, D. Torocsik, H. D'Avila, B. Dezso, K. G. Magalhaes, H. C. Castro-Faria-Neto, L. Nagy, and P. T. Bozza Mycobacterium bovis Bacillus Calmette-Guerin Infection Induces TLR2-Dependent Peroxisome Proliferator-Activated Receptor {gamma} Expression and Activation: Functions in Inflammation, Lipid Metabolism, and Pathogenesis J. Immunol., July 15, 2009; 183(2): 1337 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Sorgi, A. Secatto, C. Fontanari, W. M. Turato, C. Belanger, A. I. de Medeiros, S. Kashima, S. Marleau, D. T. Covas, P. T. Bozza, et al. Histoplasma capsulatum Cell Wall {beta}-Glucan Induces Lipid Body Formation through CD18, TLR2, and Dectin-1 Receptors: Correlation with Leukotriene B4 Generation and Role in HIV-1 Infection J. Immunol., April 1, 2009; 182(7): 4025 - 4035. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Q. Gu, S. Ikuyama, P. Wei, B. Fan, J.-i. Oyama, T. Inoguchi, and J. Nishimura Pycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophages Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1390 - E1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Murphy Jr., R. L. Rouse, W. W. Polk, W. G. Henk, S. A. Barker, M. J. Boudreaux, Z. E. Floyd, and A. L. Penn Combustion-Derived Hydrocarbons Localize to Lipid Droplets in Respiratory Cells Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 532 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Accioly, P. Pacheco, C. M. Maya-Monteiro, N. Carrossini, B. K. Robbs, S. S. Oliveira, C. Kaufmann, J. A. Morgado-Diaz, P. T. Bozza, and J. P.B. Viola Lipid Bodies Are Reservoirs of Cyclooxygenase-2 and Sites of Prostaglandin-E2 Synthesis in Colon Cancer Cells Cancer Res., March 15, 2008; 68(6): 1732 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Maya-Monteiro, P. E. Almeida, H. D'Avila, A. S. Martins, A. P. Rezende, H. Castro-Faria-Neto, and P. T. Bozza Leptin Induces Macrophage Lipid Body Formation by a Phosphatidylinositol 3-Kinase- and Mammalian Target of Rapamycin-dependent Mechanism J. Biol. Chem., January 25, 2008; 283(4): 2203 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacheco, A. Vieira-de-Abreu, R. N. Gomes, G. Barbosa-Lima, L. B. Wermelinger, C. M. Maya-Monteiro, A. R. Silva, M. T. Bozza, H. C. Castro-Faria-Neto, C. Bandeira-Melo, et al. Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 Controls Microtubule-Driven Biogenesis and Leukotriene B4-Synthesizing Function of Macrophage Lipid Bodies Elicited by Innate Immune Response J. Immunol., December 15, 2007; 179(12): 8500 - 8508. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D'Avila, P. E. Almeida, N. R. Roque, H. C. Castro-Faria-Neto, and P. T. Bozza Toll-Like Receptor-2-Mediated C-C Chemokine Receptor 3 and Eotaxin-Driven Eosinophil Influx Induced by Mycobacterium bovis BCG Pleurisy Infect. Immun., March 1, 2007; 75(3): 1507 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Wan, R. C. N. Melo, Z. Jin, A. M. Dvorak, and P. F. Weller Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies FASEB J, January 1, 2007; 21(1): 167 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. N. Melo, A. Sabban, and P. F. Weller Leukocyte lipid bodies: inflammation-related organelles are rapidly detected by wet scanning electron microscopy J. Lipid Res., November 1, 2006; 47(11): 2589 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vieira-de-Abreu, E. F. Assis, G. S. Gomes, H. C. Castro-Faria-Neto, P. F. Weller, C. Bandeira-Melo, and P. T. Bozza Allergic Challenge-Elicited Lipid Bodies Compartmentalize In Vivo Leukotriene C4 Synthesis within Eosinophils Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. van Manen, Y. M. Kraan, D. Roos, and C. Otto Single-cell Raman and fluorescence microscopy reveal the association of lipid bodies with phagosomes in leukocytes PNAS, July 19, 2005; 102(29): 10159 - 10164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogata, K. Nandate, T. Kawasaki, C. Kawasaki, M. Ozaki, and A. Shigematsu A Platelet Activating Factor Receptor Antagonist Inhibits Cytokine Production in Human Whole Blood by Bacterial Toxins and Live Bacteria Anesth. Analg., June 1, 2004; 98(6): 1767 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. de Assis, A. R. Silva, L. F. C. Caiado, G. K. Marathe, G. A. Zimmerman, S. M. Prescott, T. M. McIntyre, P. T. Bozza, and H. C. de Castro-Faria-Neto Synergism Between Platelet-Activating Factor-Like Phospholipids and Peroxisome Proliferator-Activated Receptor {gamma} Agonists Generated During Low Density Lipoprotein Oxidation That Induces Lipid Body Formation in Leukocytes J. Immunol., August 15, 2003; 171(4): 2090 - 2098. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |